LUPUS ERYTHEMATOSUS – Umbilical cord-derived allogeneic mesenchymal stem cell grafts – Recruitment is open. Request for a major protocol modification is underway to allow Covid+ LES patients access to this innovative therapy
Allogeneic mesenchymal stem cell grafts (IV injection) in severe Lupus Erythematosus refractory to standard therapies. Identifiant ClinicalTrials.gov : NCT03562065 Financement
Read more